Graham
Senior Moment
- Messages
- 5,188
- Location
- Sussex, UK
Actually "canard" has a dual meaning: duck is one, as in quackery, and "unfounded rumour" is the other. You were right the first time though, it is one of my weird pieces.
Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
This has been posted elsewhere by someone with a very good sense of humour:
NEW CANARD PASSENGER LINE
Southampton to New York in 5 days
Canard has announced the successful first voyage of its flagship, the Queen Mary Pace. Built in Oxford to rigorous specifications, this sleek and sophisticated liner, with the latest engines built with Graduated Energy Transmission, has taken the world by storm with the first crossing in just 5 days.
Contrary to what Wessely said in his mental elf blog, PACE wasn't a randomised controlled trial.
He said: "Reading some of the criticism, I am struck that some of the critics are not familiar with the fundamental strengths of the randomised control trial, and why medicine continues to value it so highly. "
And : "What makes a good trial and how does PACE measure up?
So what does the literature on randomised controlled trials tell us about the factors that are known to influence or bias the results of trials?"
He is giving the impression to readers it was a gold standard RCT, but it wasn't, SMC group wasn't a control group and the paper didn't call itself a RCT, see here:
The title of the PACE trial:
"Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial"
And in the paper:
"Methods - In our parallel-group randomised trial, patients meeting Oxford criteria for chronic fatigue syndrome"
Though the protocol paper called it a RCT in the title:
" Protocol for the PACE trial: a randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise, as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy. BMC Neurol 7:6. doi: http://dx.doi.org/10.1186/1471-2377-7-6"
And in the protocol paper in "Type of Design" they also said it was a RCT - it wasn't a RCT.
"Type of design - A four arm, randomised multi-centre parallel group controlled trial of patients who meet operationalised criteria for CFS/ME, with follow-up for 52 weeks (see Figure 1)."
Can someone who is on twitter point this out to Coyne please?
Nothing weird about it. It is a superb piece that makes a very clear point on a dreadful subject in an entertaining way. It doesn't get much better than that. I, for one, would love to see more.Actually "canard" has a dual meaning: duck is one, as in quackery, and "unfounded rumour" is the other. You were right the first time though, it is one of my weird pieces.
Perfect.The problem is that however many icebergs you point out that you missed, if you hit a big one it makes no difference.
And that, in a nutshell, is the PACE trial!this trial rather nicely shows that when you compare a placebo with a nocebo you get quite a nice placebo effect.
I have finally read the blog through. The problem is that however many icebergs you point out that you missed, if you hit a big one it makes no difference. The blog carefully avoids the one central issue - that nobody in clinical pharmacology would take this trial seriously if the treatment was a drug because of what we know about what happens with lack of blinding and subjective endpoints. Trials like this of physiotherapy in rheumatology are no longer taken any notice of because we have moved on to proper science and effective treatments.
And apparently you can claim a £5m funding grant to test that hypothesis.this trial rather nicely shows that when you compare a placebo with a nocebo you get quite a nice placebo effect.
Yes, good point. I'd noticed that too. I'd read that he'd given consultancy time.Why does Wessely deny involvement in the PACE trial? He makes quite a show of it in the blog.
...because it's a genuinely beautiful trial. It's one of the most beautiful behavioural medicine trials that we've ever seen... So, it's a fantastic and beautiful trial...
As a patient, I'm not interested or impressed by whether or not it's a good behavioural medicince trial, just if it's a good medicine trial. If behavioural trials happily accept using self-reports in unblinded trials with no attempt at placebo (such as relaxtion therapy) - and make no attempt to address those weaknesses when interpreting the trial - then it's not focusing on the interest of patients, and that's not good enough.At 16 mins, speaking about the PACE trial, Simon Wessely says: "It was the "final, kind of, definitive trial... I'm not connected with this trial. I recruited some patients for it but I was not part of it... I wish I had been...because it's a genuinely beautiful trial. It's one of the most beautiful behavioural medicine trials that we've ever seen... So, it's a fantastic and beautiful trial...
No change in fitness or walking capacity (OK a tiny gain in walking after a year of exercise) or employment status or disability claims status. (I'd thought they'd collected at least employment data for long-term follow-up - perhaps that will come later...?). Can we ground claims in the real world, please?Simon Wessley said:...We've improved the physical health, the psychological health, functioning and so on of a large number of people...